EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effectiveness of Topical Cyclosporin-A 0.1% Compared to Combined Topical Cyclosporin-A 0.1% with Topical Sodium Hyaluronate on Interleukin-6 Levels in the Tears of Patients with Dry Eye Disease

Desti Priani, Habibah S Muhiddin, Junaedi Sirajuddin, Hasnah B Eka, Burhanuddin Bahar, Agussalim Bukhari iD

Vision · 03.04.2023 · 7 (2) · 31

DOI: 10.3390/vision7020031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vision, online erschienen am 03.04.2023. Verfasst von Desti Priani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pro-inflammatory cytokines are important contributors to dry eye disease (DED). The cytokine interleukin (IL)-6 has become a therapeutic target in several DED drug studies. This randomized controlled trial aimed to determine the effectiveness of topical cyclosporin-A 0.1% compared to the combination of topical cyclosporin-A 0.1% and sodium hyaluronate in reducing tear IL-6 levels in DED patients.

Methods

The participants were 20 patients, each with two eyes, who had moderate-to-severe DED. Before and after treatment, the clinical degree of DED was examined in each group, using ocular surface disease index (OSDI) scores, tear break-up time (TBUT), fluorescent tests, and Schirmer I tests. In addition, tear samples were taken to examine IL-6 levels through the ELISA method. The results were analyzed using the t-test, Wilcoxon test, and Mann–Whitney test. The correlation between tear IL-6 levels and the severity of DED was analyzed using the Spearman correlation test.

Results

The study showed a significantly lower tear IL-6 level, OSDI score, and degree of ocular staining after either topical cyclosporin-A 0.1% or a combination of topical cyclosporin-A 0.1% and sodium hyaluronate (all values p < 0.05).

Conclusions

The combination therapy was superior in reducing tear IL-6 levels. In addition, a correlation existed between tear IL-6 levels and the severity of DED based on the TBUT, although it was weak and not statistically significant.

Schlagwörter

Stichwörter der Autor:innen

cyclosporin-Adry eyeinterleukin-6sodium-hyaluronic

Autor:innen und Institutionen

  • Department of Ophthalmology, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
  • Hasanuddin University Hospital, Makassar 90245, Indonesia.
  • Department of Public Health Medicine, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
  • Department of Clinical Nutrition, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.

ORCID-Profile: Agussalim Bukhari

Zitieren

APA

Priani, D., Muhiddin, H. S., Sirajuddin, J., Eka, H. B., Bahar, B., & Bukhari, A. (2023). Effectiveness of Topical Cyclosporin-A 0.1% Compared to Combined Topical Cyclosporin-A 0.1% with Topical Sodium Hyaluronate on Interleukin-6 Levels in the Tears of Patients with Dry Eye Disease. Vision, 7(2), 31. https://doi.org/10.3390/vision7020031

Vancouver

Priani D, Muhiddin HS, Sirajuddin J, Eka HB, Bahar B, Bukhari A. Effectiveness of Topical Cyclosporin-A 0.1% Compared to Combined Topical Cyclosporin-A 0.1% with Topical Sodium Hyaluronate on Interleukin-6 Levels in the Tears of Patients with Dry Eye Disease. Vision. 2023;7(2):31. doi:10.3390/vision7020031

BibTeX
@article{Priani2023,
  author = {Priani, Desti and Muhiddin, Habibah S and Sirajuddin, Junaedi and Eka, Hasnah B and Bahar, Burhanuddin and Bukhari, Agussalim},
  title = {Effectiveness of Topical Cyclosporin-A 0.1% Compared to Combined Topical Cyclosporin-A 0.1% with Topical Sodium Hyaluronate on Interleukin-6 Levels in the Tears of Patients with Dry Eye Disease},
  journal = {Vision},
  year = {2023},
  volume = {7},
  number = {2},
  pages = {31},
  doi = {10.3390/vision7020031}
}
Kostenlos starten →